HAPPENING NOW
The headlines, minus the noise. Updated in real time. Beta
Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds
The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after symptom ons…
AI Summary POWERED BY HAPPENING NOW AI
The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after symptom onset in the index patient, according to a Phase III randomized controlled trial published in the New England Journal of Medicine.
Read full article →AI summaries can be wrong sometimes—always verify important details using the source link below.